New Topical PDE4 Inhibitor Gets FDA Green Light for Chronic Skin Disease
(MedPage Today) -- The FDA has approved the topical phosphodiesterase 4 (PDE4) inhibitor difamilast (Adquey) as a new option for ...
(MedPage Today) -- The FDA has approved the topical phosphodiesterase 4 (PDE4) inhibitor difamilast (Adquey) as a new option for ...
(MedPage Today) -- The FDA on Thursday approved label changes for six hormone replacement therapies (HRTs) that remove boxed warnings ...
(MedPage Today) -- Note that some links may require registration or subscription. FDA vaccine chief Vinay Prasad, MD, MPH, who ...
The debate here is not about the legitimacy of mRNA vaccines. It is about whether the right comparator was chosen ...
(MedPage Today) -- The FDA approved a tumor treating fields (TTFields) device for locally advanced pancreatic cancer, the first therapy ...
(MedPage Today) -- The FDA is refusing to consider Moderna's application for a new flu vaccine made with Nobel Prize-winning ...
(MedPage Today) -- With clinician approval, reproductive-age patients prescribed isotretinoin-containing drugs for acne may complete required pregnancy testing at home ...
(MedPage Today) -- Oncology specialists should inform patients about a risk of serious toxicity related to dihydropyrimidine dehydrogenase (DPD) deficiency ...
(MedPage Today) -- Note that some links may require registration or subscription. On World Cancer Day, Princess of Wales Kate ...
(MedPage Today) -- The FDA has requested that Amgen voluntarily withdraw avacopan (Tavneos), a treatment for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.